Alzheimers & Dementia-Translational Research & Clinical Interventions

Scope & Guideline

Bridging Science and Care for Cognitive Health

Introduction

Explore the comprehensive scope of Alzheimers & Dementia-Translational Research & Clinical Interventions through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Alzheimers & Dementia-Translational Research & Clinical Interventions in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN-
PublisherWILEY
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationALZH DEMENT-TRCI / Alzheimers Dement.-Transl. Res. Clin. Interv.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal 'Alzheimers & Dementia: Translational Research & Clinical Interventions' focuses on bridging the gap between basic research and clinical applications in the field of Alzheimer's disease and related dementias. It aims to provide a platform for innovative research that offers insights into the pathophysiology, diagnosis, treatment, and care of Alzheimer's disease.
  1. Clinical Applications of Biomarkers:
    The journal emphasizes research on biomarkers that can aid in the diagnosis and monitoring of Alzheimer's disease. This includes studies on cerebrospinal fluid (CSF) biomarkers, plasma markers, and neuroimaging techniques to track disease progression.
  2. Pharmacological Interventions:
    A significant focus is on the development and evaluation of pharmacological treatments, including anti-amyloid therapies and other disease-modifying agents. This encompasses clinical trials and their design, efficacy, and safety.
  3. Social and Behavioral Aspects of Dementia Care:
    Research related to the psychosocial aspects of dementia care, including caregiver support, patient-centered care strategies, and the impact of social connections on health outcomes is a core area of interest.
  4. Health Disparities and Inclusion:
    The journal addresses issues of diversity and inclusion in Alzheimer's research, emphasizing the importance of studying underrepresented populations and understanding how social determinants affect health outcomes.
  5. Innovative Methodologies:
    The journal promotes the use of novel methods in Alzheimer's research, including machine learning, digital health technologies, and community-based participatory research approaches.
The journal has seen a rise in themes that reflect contemporary issues and advancements in Alzheimer's research. These emerging areas indicate a shift towards more integrative and inclusive approaches to understanding and treating the disease.
  1. Diversity and Inclusion in Research:
    There is an increasing emphasis on the importance of diversity in research populations, addressing health disparities, and ensuring that findings are applicable across different racial, ethnic, and socio-economic groups.
  2. Digital Health Interventions:
    The trend towards digital health solutions, including telehealth, mobile health applications, and online cognitive training programs, is gaining traction as a means to enhance patient engagement and accessibility.
  3. Personalized Medicine Approaches:
    Research that aims to tailor interventions based on individual genetic, biomarker, and lifestyle profiles is on the rise, highlighting a shift towards personalized treatment strategies for Alzheimer's disease.
  4. Holistic and Multidimensional Care Models:
    There is a growing focus on holistic care models that integrate physical, mental, and social health, recognizing the multifaceted nature of dementia and its impact on overall well-being.
  5. Community-Based Participatory Research:
    Increasingly, research methodologies that involve community engagement and collaboration with stakeholders are emerging, reflecting a commitment to addressing real-world challenges faced by individuals with dementia and their caregivers.

Declining or Waning

As the landscape of Alzheimer's research evolves, certain themes within the journal have shown a decline in prominence. This may reflect shifting priorities or advancements in other areas of research.
  1. Traditional Neuropsychological Assessments:
    There appears to be a waning focus on traditional neuropsychological assessments as primary outcomes in Alzheimer's studies, with a shift towards more dynamic and holistic measures of cognition and functionality.
  2. Single-Domain Interventions:
    Research concentrating solely on single-domain interventions, such as cognitive training or pharmacological treatments without integrated approaches, is decreasing as multidisciplinary strategies become more favored.
  3. Cultural Competency Training:
    While once a focal point, specific studies on cultural competency training for dementia care providers are becoming less frequent, possibly as the field moves towards broader systemic changes rather than isolated training programs.
  4. Basic Mechanistic Studies:
    Research centered exclusively on basic mechanistic studies without translational implications is declining, as there is a stronger emphasis on studies that can directly inform clinical practice and patient outcomes.
  5. Epidemiological Studies on Non-Dementia Populations:
    There is a noticeable reduction in studies focusing on the epidemiology of cognitive decline in non-dementia populations, as the journal pivots towards more targeted research on individuals diagnosed with Alzheimer's disease.

Similar Journals

NEUROLOGIST

Enhancing Clinical Practice with Groundbreaking Research
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1074-7931Frequency: 6 issues/year

NEUROLOGIST, an esteemed journal published by Lippincott Williams & Wilkins, serves as a vital resource in the fields of Neurology and Medicine. With an ISSN of 1074-7931 and an E-ISSN of 2331-2637, this journal has been dedicated to advancing the understanding of neurological disorders since its inception in 1996, with continual contributions through 2024. Achieving a respectable Q3 rank in both Medicine (miscellaneous) and Neurology (clinical), it provides an essential platform for disseminating innovative research and clinical studies. Although it is not an open-access publication, NEUROLOGIST promotes a rich exchange of ideas and findings for researchers, healthcare professionals, and students alike, helping to bridge the gaps in neurological research and practice. The journal is recognized for its commitment to enhancing clinical practice and research methodology, making it a valuable asset for anyone engaged in the dynamic field of neurology.

Annals of Geriatric Medicine and Research

Empowering research for healthier aging.
Publisher: KOREAN GERIATRIC SOCISSN: 2508-4909Frequency: 4 issues/year

Annals of Geriatric Medicine and Research, published by the Korean Geriatric Society, is a premier open-access journal dedicated to advancing the understanding of geriatric medicine and gerontology. Since its inception in 1997, the journal has played a crucial role in disseminating significant research findings, policy discussions, and clinical innovations that address the complexities of elderly healthcare. Based in South Korea, the journal has gained recognition with an impact factor reflecting its Q2 ranking in the field of Geriatrics and Gerontology for 2023, placing it competitively within its category among 116 journals. Researchers, healthcare professionals, and students will find comprehensive insights ranging from clinical studies to public health strategies crucial for enhancing the quality of life of older adults. With a commitment to open access, the journal ensures that its valuable information is freely available, fostering collaboration and knowledge-sharing that is vital in this dynamic field.

JAMA Psychiatry

Unraveling the Complexities of Psychiatry for Global Impact
Publisher: AMER MEDICAL ASSOCISSN: 2168-622XFrequency: 12 issues/year

JAMA Psychiatry, published by the American Medical Association, stands as a leading peer-reviewed journal in the fields of psychiatry and mental health, featuring an impressive impact factor that reflects its significance in advancing research and clinical practice. With an ISSN of 2168-622X and an E-ISSN of 2168-6238, this journal operates on a comprehensive access model that allows for the dissemination of vital research findings to a global audience. Since its inception in 2013, JAMA Psychiatry has consistently ranked in the top quartile (Q1) in both the Medicine (miscellaneous) and Psychiatry and Mental Health categories, with a remarkable Scopus rank of #4 out of 567, placing it in the 99th percentile. Addressed from its headquarters in Chicago, Illinois, the journal's objectives encompass the publication of original clinical research, innovative treatment strategies, and insightful reviews that enrich the understanding of psychiatric disorders. By bridging the gap between research and real-world application, JAMA Psychiatry remains an essential resource for researchers, clinicians, and students dedicated to improving mental health outcomes.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Innovative Insights: Bridging Geriatrics and Mental Health
Publisher: ELSEVIER SCIENCE INCISSN: 1064-7481Frequency: 12 issues/year

American Journal of Geriatric Psychiatry, published by Elsevier Science Inc, stands as a leading journal in the fields of geriatrics and gerontology, as well as psychiatry and mental health, recognized with a Q1 ranking in both categories for 2023. With a robust ISSN of 1064-7481 and E-ISSN 1545-7214, this journal has been a vital resource since its inception in 1993, contributing to the academic discourse surrounding the mental health of older adults. The journal focuses on publishing high-quality research and reviews that address the complexities of psychiatric disorders in geriatric populations, making it essential reading for researchers, professionals, and students dedicated to enhancing the mental well-being of elderly individuals. Notably, it achieves impressive Scopus rankings, sitting at the 5th percentile in Geriatrics and Gerontology and 24th percentile in Psychiatry and Mental Health, underscoring its impact and relevance in the academic community. While it does not offer open access, the journal's comprehensive content is vital for those looking to stay informed on the latest advancements in geriatric psychiatry. For more information, readers can access it via Elsevier's educational platforms.

American Journal of Alzheimers Disease and Other Dementias

Advancing knowledge in neurodegenerative diseases.
Publisher: SAGE PUBLICATIONS INCISSN: 1533-3175Frequency: 81 issues/year

The American Journal of Alzheimer's Disease and Other Dementias, published by SAGE Publications Inc, is a pivotal resource for researchers, clinicians, and students engaged in the study of neurodegenerative diseases, particularly Alzheimer’s disease and various forms of dementia. With an impact factor reflecting its significance in the field, the journal boasts an open-access format since 2020, ensuring that groundbreaking research is accessible to a global audience. The journal holds prestigious Q2 rankings across several categories, including Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Covering a wide spectrum from 1986 to 2024, it provides essential insights into innovative treatments, care strategies, and the latest findings in dementia research, solidifying its importance in fostering knowledge and advancing the field. With a commitment to high-quality scholarship, this journal is an indispensable tool for advancing understanding in the dynamic landscape of dementia studies.

JOURNAL OF ALZHEIMERS DISEASE

Empowering professionals with cutting-edge research.
Publisher: IOS PRESSISSN: 1387-2877Frequency: 24 issues/year

Journal of Alzheimer's Disease, published by IOS Press, stands as a pivotal resource in the fight against Alzheimer's and related neurodegenerative disorders. With an ISSN of 1387-2877 and an E-ISSN of 1875-8908, this esteemed journal has evolved since its inception in 1998, providing a vital platform for academic research and clinical practice in the realms of Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Ranked in the Q1 category across several disciplines, including Clinical Psychology and Geriatrics, this journal not only highlights significant advancements in understanding Alzheimer's disease but also fosters interdisciplinary dialogue among researchers, healthcare professionals, and policymakers. Boasting robust Scopus rankings—such as 49th in Clinical Psychology and 29th in Geriatrics—this journal is committed to disseminating high-quality research that informs both therapeutic strategies and public health initiatives. The Journal of Alzheimer's Disease is an essential resource for anyone dedicated to exploring the complexities of cognitive decline and enhancing care for affected individuals.

ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Exploring innovative solutions for Alzheimer’s care and research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0893-0341Frequency: 4 issues/year

ALZHEIMER DISEASE & ASSOCIATED DISORDERS, published by Lippincott Williams & Wilkins, is a pivotal journal for advancing knowledge in the fields of clinical psychology, geriatric medicine, and psychiatry. With a history spanning from 1987 to 2024, this journal provides a comprehensive platform for researchers and clinicians to disseminate significant findings related to Alzheimer's disease and associated cognitive disorders. Ranked within the second and third quartiles in various categories, including clinical psychology and geriatrics, it retains a solid academic reputation, indicated by its diverse Scopus rankings, such as #137 in Clinical Psychology and #20 in Nursing & Gerontology. Although it does not offer open access, the journal is recognized for its commitment to peer-reviewed research, making it a valuable resource for professionals and students alike, aiming to stay abreast of the latest developments and evidence-based practices in Alzheimer’s and associated conditions.

Dementia-International Journal of Social Research and Practice

Empowering practitioners with high-impact dementia studies.
Publisher: SAGE PUBLICATIONS LTDISSN: 1471-3012Frequency: 8 issues/year

Dementia - International Journal of Social Research and Practice, published by SAGE Publications Ltd, is a premier peer-reviewed journal dedicated to advancing research in the multifaceted arena of dementia care and social interventions. Founded in 2002, this journal has steadily established itself as a key resource for academics and practitioners alike, reflected by its esteemed rankings in the Q1 category across multiple disciplines, including History, Medicine (Miscellaneous), Social Sciences (Miscellaneous), and Sociology and Political Science. With a remarkable Scopus rank of #28 in General Social Sciences and a 90th percentile standing, the journal champions high-impact articles that address the complexities of dementia through interdisciplinary lenses. Although it is not an open-access publication, it provides invaluable insights and cutting-edge research to its subscribers and contributors. This journal is pivotal for anyone engaged in dementia research and practice, offering not only findings from empirical studies but also fostering dialogue on social policies and care practices that enhance the lives of those affected by dementia.

BMC Geriatrics

Innovating care, enriching lives in geriatrics.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Geriatrics is a leading open-access journal dedicated to advancing the field of geriatrics and gerontology. Published by BMC, this esteemed journal has been at the forefront of research since its inception in 2001, providing a vital platform for sharing innovative studies and insights that address the complexities of aging. With an impressive Q1 ranking in the 2023 category of Geriatrics and Gerontology and a solid Scopus ranking at #40 out of 116, BMC Geriatrics showcases high-impact research that influences clinical practices and policy-making. As a fully open-access publication, it ensures that groundbreaking research is freely available to researchers, practitioners, and students alike, promoting the diffusion of knowledge across the global healthcare community. This journal is crucial for anyone interested in the latest developments in elderly care, health issues affecting aging populations, and innovative interventions designed to improve quality of life among older adults.

PSYCHOLOGICAL MEDICINE

Uncovering transformative research in mental health.
Publisher: CAMBRIDGE UNIV PRESSISSN: 0033-2917Frequency: 16 issues/year

PSYCHOLOGICAL MEDICINE is a leading journal in the field of psychiatry and psychology, published by Cambridge University Press. With its ISSN 0033-2917 and E-ISSN 1469-8978, this journal has firmly established itself as a premier platform for cutting-edge research since its inception in 1970. It consistently ranks in the top quartile for both Applied Psychology and Psychiatry and Mental Health, reflecting its exceptional impact in the field, with a 2023 Scopus ranking of #36 out of 567 in Psychiatry and Mental Health, and #21 out of 249 in Applied Psychology. The journal aims to publish comprehensive studies that explore the interplay between psychological phenomena and medical health, contributing vital insights that advance both theoretical understanding and clinical practice. Although it is not an Open Access journal, PSYCHOLOGICAL MEDICINE remains a vital resource for researchers, professionals, and students committed to the scientific investigation of mental health issues.